Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Punica granatum skin extract is a botanical extract derived from the skin (peel) of the pomegranate fruit. It is rich in various bioactive compounds, including polyphenols such as ellagic acid, punicalagin, gallic acid, anthocyanins, and flavonoids, as well as vitamins (C, B) and trace elements. This extract is recognized for its potent antioxidant, anti-inflammatory, and antimicrobial properties. It functions by neutralizing free radicals, reducing inflammatory responses, and inhibiting the growth of various microorganisms. Additionally, it has been shown to inhibit melanogenesis and tyrosinase activity, modulate collagen and hyaluronic acid metabolism, stimulate cellular renewal, and offer photoprotective effects against UV radiation. It is widely utilized in the cosmetic, skincare, and dietary supplement industries for its beneficial effects on skin health, including reducing wrinkles, improving skin radiance, elasticity, firmness, and addressing concerns like hyperpigmentation and acne.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on punica granatum skin extract.